1. Home
  2. NXL vs FEDU Comparison

NXL vs FEDU Comparison

Compare NXL & FEDU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXL
  • FEDU
  • Stock Information
  • Founded
  • NXL 2010
  • FEDU 2007
  • Country
  • NXL United States
  • FEDU China
  • Employees
  • NXL N/A
  • FEDU N/A
  • Industry
  • NXL Medical Specialities
  • FEDU
  • Sector
  • NXL Health Care
  • FEDU
  • Exchange
  • NXL Nasdaq
  • FEDU NYSE
  • Market Cap
  • NXL 24.2M
  • FEDU 20.0M
  • IPO Year
  • NXL 2022
  • FEDU 2017
  • Fundamental
  • Price
  • NXL $1.17
  • FEDU $7.70
  • Analyst Decision
  • NXL Strong Buy
  • FEDU
  • Analyst Count
  • NXL 1
  • FEDU 0
  • Target Price
  • NXL $5.00
  • FEDU N/A
  • AVG Volume (30 Days)
  • NXL 121.2K
  • FEDU 7.4K
  • Earning Date
  • NXL 05-20-2025
  • FEDU 12-20-2024
  • Dividend Yield
  • NXL N/A
  • FEDU 29.57%
  • EPS Growth
  • NXL N/A
  • FEDU N/A
  • EPS
  • NXL N/A
  • FEDU 0.12
  • Revenue
  • NXL $168,721.00
  • FEDU $27,971,139.00
  • Revenue This Year
  • NXL $79.59
  • FEDU N/A
  • Revenue Next Year
  • NXL $334.65
  • FEDU N/A
  • P/E Ratio
  • NXL N/A
  • FEDU $63.77
  • Revenue Growth
  • NXL 52.35
  • FEDU 141.14
  • 52 Week Low
  • NXL $0.53
  • FEDU $3.69
  • 52 Week High
  • NXL $4.49
  • FEDU $22.70
  • Technical
  • Relative Strength Index (RSI)
  • NXL 23.87
  • FEDU 48.16
  • Support Level
  • NXL $1.75
  • FEDU $7.30
  • Resistance Level
  • NXL $1.39
  • FEDU $7.71
  • Average True Range (ATR)
  • NXL 0.14
  • FEDU 0.36
  • MACD
  • NXL -0.04
  • FEDU 0.12
  • Stochastic Oscillator
  • NXL 6.63
  • FEDU 83.55

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops neurostimulation products to uniquely and effectively help combat the ongoing mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

About FEDU FOUR SEASONS EDUCATION (CAYMAN) INC SPON ADS EACH REP 10 ORD SHS(R/S)

Four Seasons Education (Cayman) Inc is engaged in the provision of after-school education services for kindergarten, elementary and middle school students. The Company derives its revenue from learning services, tourism services, and learning technology and content solutions. The company is a comprehensive educational enterprise that provides research practice services, educational informatization equipment, high-quality educational resources, and teacher training, as well as a digital publishing business, and continues to expand in educational research and educational informatization.

Share on Social Networks: